Literature DB >> 2350021

Direct and neurally mediated effects of halothane on pulmonary resistance in vivo.

D O Warner1, J Vettermann, J F Brichant, K Rehder.   

Abstract

It has been suggested that halothane inhibits contraction of airway smooth muscle in vivo mainly by reducing reflex activity in nerves innervating the muscle with only minimal direct effects on the muscle itself. To examine possible mechanisms of action of halothane at clinically relevant concentrations the authors studied the effect of halothane on increases in pulmonary resistance (RL) produced by either vagus nerve stimulation (VNS, which caused neurally mediated constriction) or the inhalation of nebulized acetylcholine (ACh, which directly stimulated the smooth muscle cell) in nine mongrel dogs. The frequency of bilateral VNS and the dose of nebulized ACh were adjusted to produce approximately equal increases in RL. Halothane reduced the response to both types of stimulation in a dose-dependent fashion. At halothane concentrations greater than or equal to 0.4 MAC, the VNS response was significantly less than the ACh response. When tetrodotoxin was given to block neural activity, the ACh response was unchanged, confirming that neural activation did not contribute significantly to smooth muscle contraction in response to ACh. The authors conclude that in addition to neurally mediated effects, halothane at clinically used concentrations has significant direct effects on airway smooth muscle stimulated by ACh. The relative importance of each factor in vivo should depend on the stimulus that causes contraction of airway smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2350021     DOI: 10.1097/00000542-199006000-00017

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

Review 1.  HRCT imaging of airway responsiveness: effects of anesthetics.

Authors:  R H Brown
Journal:  J Clin Monit Comput       Date:  2000       Impact factor: 2.502

2.  Targeted Versus Continuous Delivery of Volatile Anesthetics During Cholinergic Bronchoconstriction.

Authors:  Jarred R Mondoñedo; John S McNeil; Jacob Herrmann; Brett A Simon; David W Kaczka
Journal:  J Eng Sci Med Diagn Ther       Date:  2018-05-09

3.  Isoflurane for life-threatening bronchospasm: a 15-year single-center experience.

Authors:  David A Turner; David Heitz; Mehrengise K Cooper; P Brian Smith; John H Arnold; Scot T Bateman
Journal:  Respir Care       Date:  2012-03-13       Impact factor: 2.258

4.  Volatile Anesthetics and the Treatment of Severe Bronchospasm: A Concept of Targeted Delivery.

Authors:  Jarred R Mondoñedo; John S McNeil; Samir D Amin; Jacob Herrmann; Brett A Simon; David W Kaczka
Journal:  Drug Discov Today Dis Models       Date:  2014-04-29

5.  Low-dose halothane produces airway dilatation but does not alter parenchymal mechanics in the normal canine lung.

Authors:  J Sato; N Shinozuka; A Kochi; H Uchida; T Mizuguchi
Journal:  Can J Anaesth       Date:  1995-05       Impact factor: 5.063

Review 6.  Desflurane. A review of its pharmacodynamic and pharmacokinetic properties and its efficacy in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1995-10       Impact factor: 9.546

7.  Volatile anaesthetic for treatment of respiratory failure from status asthmaticus requiring extracorporeal membrane oxygenation.

Authors:  Joseph E LaGrew; Kevin Robert Olsen; Amanda Frantz
Journal:  BMJ Case Rep       Date:  2020-01-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.